logo-loader

Omega Diagnostics Group Plc

Receive alerts
Market:
AIM
Market Cap:
£19.92 m
Price
13.25 GBX
Change
8.16%
52 weeks high
14.25
52 weeks low
8.19

In brief

Omega Diagnostics Group PLC is a United Kingdom-based holding company. The Company, along with its subsidiaries, is principally engaged in the manufacture, development and distribution of medical diagnostic products. On September 3, 2007, the Company acquired 100% of the voting shares of Genesis Diagnostics Ltd (Genesis) and Cambridge Nutritional Sciences Ltd (CNS). Genesis operates in the medical diagnostics industry developing, producing and selling a range of test kits specializing in the areas of autoimmune disease, infectious diseases and food intolerance. CNS provides a testing service for food intolerance and various other diseases.

Latest

RNS

Holding(s) in Company

5 days, 23 hours ago
RNS

Grant of Share Options

1 week, 6 days ago
RNS

Interim Results

1 week, 6 days ago
RNS

Update on Allergy test menu

2 weeks, 6 days ago
RNS

Investor results briefing

3 weeks, 3 days ago
RNS

Result of AGM

on 22/10/19